Does adverse events due to tirosine kinase inhibıtor s mean good efficacy in chronic myeloid leukemia patients

AKINCI S., SILAY K., ULAŞ A., BAKANAY ÖZTÜRK Ş. M., AKINCI M. B., DİLEK İ.

5th International Congress Leukemia Lymphoma Myeloma May 21-23, 2015 İstanbul, 21 - 23 May 2015

• Publication Type: Conference Paper
• Ankara Yıldırım Beyazıt University Affiliated: Yes